Liminatus Pharma, Inc. (LIMN) earnings

Quarterly and annual LIMN reports and results, each read against the price at its own news timestamp. Back to the LIMN overview →

8 measured LIMN earnings events.

DateHeadlineEvent5-minTo close
Form 10-Q Liminatus Pharma, Inc. For: Jun 30SEC filing · Form 10-Q+1.69%+8.77%
Form 10-Q Liminatus Pharma, Inc. For: Mar 31SEC filing · Form 10-Q-2.67%+0.05%
Form 10-K Liminatus Pharma, Inc. For: Dec 31SEC filing · Form 10-K+0.00%-0.64%
Form 10-Q Liminatus Pharma, Inc. For: Sep 30SEC filing · Form 10-Q+3.91%+4.90%
Form 10-Q Liminatus Pharma, Inc. For: Jun 30SEC filing · Form 10-Q-3.41%-1.71%
Form NT 10-Q Liminatus Pharma, Inc. For: Jun 30SEC filing · Form NT-7.19%-4.08%
Form 10-Q Liminatus Pharma, Inc. For: Mar 31SEC filing · Form 10-Q-3.64%-2.00%
Form NT 10-Q Liminatus Pharma, Inc. For: Mar 31SEC filing · Form NT+2.71%-2.86%
Get an email when LIMN moves on news →
Keep exploring

More LIMN: analyst actions → · SEC filings → · LIMN overview →